A practical nomogram based on systemic inflammatory markers for predicting portal vein thrombosis in patients with liver cirrhosis

References

• Consensus for management of portal vein thrombosis in liver cirrhosis (2020, shanghai). J Dig Dis. 2021;22(4):176–186.
   PubMed Web of Science ®Google Scholar
• Gîrleanu I, Trifan A, Stanciu C, et al. Portal vein thrombosis in cirrhotic patients – it is always the small pieces that make the big picture. World J Gastroenterol. 2018;24(39):4419–4427.
   PubMed Web of Science ®Google Scholar
• Samant H, Asafo-Agyei KO, Garfield K. Portal vein thrombosis. Treasure Island (FL): StatPearls Publishing; 2021.
   Google Scholar
• Senzolo M, Garcia-Tsao G, García-Pagán J. Current knowledge and management of portal vein thrombosis in cirrhosis. J Hepatol. 2021;75(2):442–459.
   PubMed Web of Science ®Google Scholar
• Guo L, Rondina MJFii. The era of thromboinflammation: platelets are dynamic sensors and effector cells during infectious diseases. Front Immunol. 2019;10:2204.
   PubMed Web of Science ®Google Scholar
• Kuplay H, Erdoğan SB, Bastopcu M, et al. The neutrophil-lymphocyte ratio and the platelet-lymphocyte ratio correlate with thrombus burden in deep venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2020;8(3):360–364.
   PubMedGoogle Scholar
• Farah R, Nseir W, Kagansky D, et al. The role of neutrophil-lymphocyte ratio, and mean platelet volume in detecting patients with acute venous thromboembolism. J Clin Lab Anal. 2020;34(1):e23010.
   PubMed Web of Science ®Google Scholar
• Tekesin A, Tunç A. Inflammatory markers are beneficial in the early stages of cerebral venous thrombosis. Arq Neuro-Psiquiatr. 2019;77(2):101–105.
   PubMed Web of Science ®Google Scholar
• Liu D, Zhu Y, Chen W, et al. Relationship between the inflammation/immune indexes and deep venous thrombosis (DVT) incidence rate following tibial plateau fractures. J Orthop Surg Res. 2020;15(1):241.
   PubMed Web of Science ®Google Scholar
• Carr BI, Guerra V, Donghia R. Portal vein thrombosis and markers of inflammation in hepatocellular carcinoma. J Gastrointest Cancer. 2020;51(4):1141–1147.
   PubMed Web of Science ®Google Scholar
• Di Minno M, Calcaterra I, Lupoli R, et al. Hemostatic changes in patients with COVID-19: a meta-analysis with meta-regressions. J Clin Med.2020;9(7):2244.
   Google Scholar
• Xu W, Cheng Y, Tu B. [Construction and validation of a nomogram for predicting the risk of portal vein thrombosis after splenectomy in patients with hepatitis B cirrhosis]. J South Med Univ. 2020;40(9):1265–1272.
   Google Scholar
• Yuan HL, Wang M, Chu WW, et al. Nomogram model for prediction of portal vein thrombosis in patients with liver cirrhosis after splenectomy: a retrospective analysis of 2 independent cohorts. Med Sci Monit. 2021;27:e929844
   PubMed Web of Science ®Google Scholar
• von Köckritz L, De Gottardi A, Trebicka J, et al. Portal vein thrombosis in patients with cirrhosis. Gastroenterol Rep. 2017;5(2):148–156.
   Google Scholar
• Zhang Y, Xu B, Wang X, et al. Prevalence and clinical significance of portal vein thrombosis in patients with cirrhosis and acute decompensation. Clin Gastroenterol Hepatol. 2020;18(11):2564–2572.e1.
   PubMed Web of Science ®Google Scholar
• Malaguarnera M, Latteri S, Bertino G, et al. D-dimer plasmatic levels as a marker for diagnosis and prognosis of hepatocellular carcinoma patients with portal vein thrombosis. CEG. 2018;11:373–380.
   Google Scholar
• Li-Gao R, Morelli VM, Lijfering WM, et al. Glucose levels and diabetes are not associated with the risk of venous thrombosis: results from the MEGA case-control study. Br J Haematol. 2019;184(3):431–435.
   PubMed Web of Science ®Google Scholar
• Gariani K, Mavrakanas T, Combescure C, et al. Is diabetes mellitus a risk factor for venous thromboembolism? A systematic review and meta-analysis of case-control and cohort studies. Eur J Intern Med. 2016;28:52–58.
   PubMed Web of Science ®Google Scholar
• Jiang GQ, Bai DS, Chen P, et al. Predictors of portal vein system thrombosis after laparoscopic splenectomy and azygoportal disconnection: a retrospective cohort study of 75 consecutive patients with 3-months follow-up. Int J Surg. 2016;30:143–149.
   PubMed Web of Science ®Google Scholar
• Naymagon L, Tremblay D, Mascarenhas J, et al. Characteristics, anticoagulation, and outcomes of portal vein thrombosis after intra-abdominal surgery. Surgery. 2021;169(5):1175–1181.
   PubMed Web of Science ®Google Scholar
• Lu S, Hu G, Chen S, et al. Risk factors of portal vein thrombosis after devascularization treatment in patients with liver cirrhosis: a nested case-control study. Biomed Res Int. 2020; 2020:9583706.
   PubMed Web of Science ®Google Scholar
• Intagliata NM, Caldwell SH, Tripodi A. Diagnosis, development, and treatment of portal vein thrombosis in patients with and without cirrhosis. Gastroenterology. 2019;156(6):1582–1599.e1.
   PubMed Web of Science ®Google Scholar
• Ogawa S, Yamamoto A, Jogo A, et al. Splenic vein diameter is a risk factor for the portal venous system thrombosis after partial splenic artery embolization. Cardiovasc Intervent Radiol. 2021;44(6):921–930.
   PubMed Web of Science ®Google Scholar
• Kuroki T, Kitasato A, Tokunaga T, et al. Predictors of portal and splenic vein thrombosis after laparoscopic splenectomy: a retrospective analysis of a single-center experience. Surg Today. 2018;48(8):804–809.
   PubMed Web of Science ®Google Scholar
• de’Angelis N, Abdalla S, Lizzi V, et al. Incidence and predictors of portal and splenic vein thrombosis after pure laparoscopic splenectomy. Surgery. 2017;162(6):1219–1230.
   PubMed Web of Science ®Google Scholar
• Luo N, Wang Y, Geng Z, et al. Analysis of feasibility, safety and effectiveness of ultrasound-guided percutaneous microwave ablation of splenic neoplasm. Oncol Lett. 2018;16(4):4807–4812.
   PubMed Web of Science ®Google Scholar
• Vadera S, Yong CWK, Gluud LL, et al. Band ligation versus no intervention for primary prevention of upper gastrointestinal bleeding in adults with cirrhosis and oesophageal varices. Cochrane Database Syst Rev. 2019;6(6):Cd012673.
   PubMedGoogle Scholar
• Lin OS, Wu SS, Chen YY, et al. Bacterial peritonitis after elective endoscopic variceal ligation: a prospective study. Am J Gastroenterol. 2000;95(1):214–217.
   PubMed Web of Science ®Google Scholar
• Maimone S, Saffioti F, Filomia R, et al. Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis. Dig Liver Dis. 2018;50(4):366–369.
   PubMedGoogle Scholar
• Tao Y, Tian K, Chen J, et al. Network pharmacology-based prediction of the active compounds, potential targets, and signaling pathways involved in danshiliuhao granule for treatment of liver fibrosis. Evid Based Complement Alternat Med. 2019; 2019:2630357.
   PubMed Web of Science ®Google Scholar
• EASL clinical practice guidelines: vascular diseases of the liver. J Hepatol. 2016;64(1):179–202.
   PubMed Web of Science ®Google Scholar